Role of Vonoprazan-Amoxicillin Dual Therapy in Pediatric Refractory Helicobacter Pylori Infection in Children: Early Experience From A Single-Center Case Series
Abstract
ABSTRACT This small case series presents real-world experience on the efficacy of dual therapy with vonoprazan and amoxicillin in pediatric patients with refractory, antimicrobial-resistant Helicobacter pylori infection and highlights the role of adequate acid suppression in treatment success. Dual therapy with vonoprazan and amoxicillin was well tolerated and resulted in successful eradication in all patients.
How strong is the evidence?
Evidence Hub reads this as a case series, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- Improving sleep quality leads to better mental health: A meta-analysis of randomised controlled trials
- Determination of ecological significance based on geostatistical assessment: a case study from the Slovak Natura 2000 protected area
- Routledge Handbook of the Study of the Commons
- Farmers' acceptance of results-based agri-environmental schemes: A German perspective
- Approaches to Identify the Value of Seminatural Habitats for Conservation Biological Control
- Overview of Helicobacter pylori Infection, Prevalence, Risk Factors, and Its Prevention
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.